tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
ABUS is currently covered by 3 analysts with an average price target of $4.49. This is a potential upside of $1.57 (53.77%) from yesterday's end of day stock price of $2.92.
Arbutus Biopharma Corp's activity chart (see below) currently has 60 price targets and 61 ratings on display. The stock rating distribution of ABUS is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 34.75% with an average time for these price targets to be met of 63.6 days.
Highest price target for ABUS is $5, Lowest price target is $4, average price target is $4.49.
Most recent stock forecast was given by ROY BUCHANAN from JMP on 04-Apr-2024. First documented stock forecast 22-Sep-2014.
Currently out of the existing stock ratings of ABUS, 19 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
4
$0.91 (29.45%)
4
15 days ago
0/5 (0%)
$1 (33.33%)
Buy
4
$0.91 (29.45%)
6
1 months 18 days ago
1/8 (12.5%)
$1.21 (43.37%)
139
Buy
5
$1.91 (61.81%)
6
1 months 18 days ago
0/13 (0%)
$2.21 (79.21%)
Buy
5
$2.08 (71.23%)
2 years 2 months 17 days ago
0/1 (0%)
$2.11 (73.01%)
Buy
7
2 years 9 months 22 days ago
0/4 (0%)
$3.7 (112.12%)
What is ABUS (Arbutus Biopharma Corp) average time for price targets to be met?
Which analyst has the current highest performing score on ABUS (Arbutus Biopharma Corp) with a proven track record?
Which analyst has the most public recommendations on ABUS (Arbutus Biopharma Corp)?
Which analyst is the currently most bullish on ABUS (Arbutus Biopharma Corp)?
Which analyst is the currently most reserved on ABUS (Arbutus Biopharma Corp)?
